Affymetrix (Santa Clara, California) Releases Comprehensive Validated Data from the Axiom(TM) Genomic Database

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ: AFFX) today announced the release of a complete data set of 5 million variants on its website. The genotyping data set, part of the Axiom™ Genomic Database, is based on extensive validation of genomic variants from the Single Nucleotide Polymorphism Database (dbSNP), 1000 Genomes Project, NHGRI Database of Published Associations, and collaborations that have led to the discovery of novel SNPs and insertion/deletions (indels). The data set includes genotyping data for more than 2 million validated rare and common genomic variants that Affymetrix recently contributed to the 1000 Genomes Project, many of which were not previously available from any source. The data will be incorporated into the 1000 Genomes Project’s public data repository.

MORE ON THIS TOPIC